D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 9.69% |
| 2 | Consumer Discretionary | 9.53% |
| 3 | Technology | 9.28% |
| 4 | Healthcare | 8.29% |
| 5 | Financials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Sabre
SABR
$743M
| $1.38M | ﹤0.01% |
+56,833
| New | +$1.22M |
|
2277
Scully Royalty
SRL
$76.7M
| $1.38M | ﹤0.01% |
68,030
-10,818
| -14% | -$253K |
|
|
RAI
2278
PUT
DELISTED
Reynolds American Inc
RAI
| $1.38M | ﹤0.01% |
40,000
-446,200
| -92% | -$15.6M |
|
2279
Northwest Bancshares
NWBI
$2.33B
| $1.38M | ﹤0.01% |
116,201
+68,998
| +146% | +$820K |
|
|
SMRT
2280
DELISTED
Stein Mart Inc
SMRT
| $1.38M | ﹤0.01% |
110,582
+6,381
| +6% | +$90.2K |
|
|
BKS
2281
DELISTED
Barnes & Noble
BKS
| $1.38M | ﹤0.01% |
88,462
-94,336
| -52% | -$1.48M |
|
|
RWT
2282
Redwood Trust
RWT
$585M
| $1.37M | ﹤0.01% |
76,873
+22,108
| +40% | +$429K |
|
2283
Sixth Street Specialty
TSLX
$1.68B
| $1.37M | ﹤0.01% |
79,810
+39,007
| +96% | +$685K |
|
2284
CALL
Zions Bancorporation
ZION
$10.1B
| $1.37M | ﹤0.01% |
50,900
-143,500
| -74% | -$3.76M |
|
|
FRM
2285
DELISTED
FURMANITE CORPORATION COM
FRM
| $1.37M | ﹤0.01% |
173,776
+69,850
| +67% | +$522K |
|
2286
PUT
Deere & Co
DE
$173B
| $1.37M | ﹤0.01% |
15,600
-249,300
| -94% | -$22.1M |
|
|
PTLA
2287
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.37M | ﹤0.01% |
36,050
+6,941
| +24% | +$238K |
|
|
NBIS
2288
PUT
Nebius Group N.V.
NBIS
$43.1B
| $1.36M | ﹤0.01% |
90,000
+39,900
| +80% | +$642K |
|
2289
CALL
Generac Holdings
GNRC
$11.5B
| $1.36M | ﹤0.01% |
28,000
-47,600
| -63% | -$2.27M |
|
|
ANAT
2290
DELISTED
American National Group, Inc. Common Stock
ANAT
| $1.36M | ﹤0.01% |
13,836
+7,440
| +116% | +$765K |
|
|
XENT
2291
DELISTED
Intersect ENT, Inc
XENT
| $1.36M | ﹤0.01% |
52,674
+22,162
| +73% | +$507K |
|
2292
AAR Corp
AIR
$5.62B
| $1.36M | ﹤0.01% |
44,303
-27,304
| -38% | -$809K |
|
2293
PUT
EQT Corp
EQT
$32.3B
| $1.36M | ﹤0.01% |
30,127
+18,370
| +156% | +$779K |
|
|
AUD
2294
DELISTED
Audacy, Inc.
AUD
| $1.36M | ﹤0.01% |
111,768
-11,881
| -10% | -$142K |
|
|
TYPE
2295
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $1.36M | ﹤0.01% |
41,592
+1,957
| +5% | +$60.6K |
|
2296
PUT
F5
FFIV
$22.8B
| $1.36M | ﹤0.01% |
11,800
-71,300
| -86% | -$8.39M |
|
2297
OraSure Technologies
OSUR
$277M
| $1.35M | ﹤0.01% |
206,862
+154,473
| +295% | +$1.28M |
|
|
ORIG
2298
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
| $1.35M | ﹤0.01% |
22
-4
| -15% | -$287K |
|
2299
Bank OZK
OZK
$5.62B
| $1.35M | ﹤0.01% |
+36,572
| New | +$1.3M |
|
2300
PUT
Cenovus Energy
CVE
$51.6B
| $1.35M | ﹤0.01% |
80,000
+10,000
| +14% | +$184K |
|
Similar funds
D.E. Shaw & Co's Q1 2015 Portfolio in Review
As of Q1 2015, D.E. Shaw & Co held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 9.7% of assets, up from 8% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, D.E. Shaw & Co opened a new position in SPDR Gold Trust worth $231M.
- D.E. Shaw & Co's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- D.E. Shaw & Co's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- D.E. Shaw & Co fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- D.E. Shaw & Co opened 448 new positions and closed 828 in Q1 2015.
- D.E. Shaw & Co's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.